Health Wildcatters Launches HW Venture Center to Foster Investor-Startup Matchmaking
Fourteen investors have committed to offering office hours at the HW Venture Center in July and August.
Draig Therapeutics Emerges With $140M for Clinical Tests of Novel Neuropsychiatric Drugs
Draig Therapeutics’ lead drug is designed to safely target the AMPA receptor as a way of mediating the interplay between two neurotransmitters whose imbalance is associated with mood disorders. The startup is one of several that have recently raised mega rounds of financing to support programs in the clinic or entering clinical testing.
What Are Healthcare Organizations Getting Wrong about Email Security?
A new report by Paubox calls for healthcare IT leaders to dispose of outdated assumptions about email security and address the challenges of evolving cybersecurity threats.
Investors Share How Early Stage Healthcare Startups Are Using AI
Business banking provider* Mercury sponsored a webinar discussing early stage investment topics with venture capitalists such as grant funding secrets, capital valuation, the role of AI in life sciences, and more.
WHAM Introduces Investor Network to Advance Women’s Health
Women's Health Access Matters recently launched the Innovator's Circle, which brings together leaders from women’s health-focused funds, including Amboy Street Ventures, Emmeline Ventures and March of Dimes.
Investors Share How Early Stage Healthcare and Life Science Startups Can Make the Most of New Opportunities
In a webinar sponsored by fintech business Mercury, investors from Breyer Capital and MBX Capital shared their startup trend perspectives on AI, valuation, and alternative funding.
Get a Snapshot of the Early Stage Life Science Startup Landscape
A webinar scheduled for Thursday May 8 at 1 pm ET sponsored by Mercury will explore how early-stage medtech and biopharma investors are looking at the market and how they're advising startups in the wake of cuts to NIH and SBIR grants.
Solving Healthcare’s Provider Data Problem Starts with Interoperability
Break down the silos. Take control of your provider data.
Time is Running Out to Join the Healthcare Innovation Conversation at INVEST 2025
MedCity INVEST is a boutique healthcare investor conference scheduled for May 20-21 at the Willis Tower in Chicago. Register today!
Why One Healthcare Founder Never Took Venture Capital
Randy Bolyga, founder CEO of RXNT, built his medical software company without venture capital, relying instead on SBA loans and a conservative, cash-positive growth strategy. He believes many venture capital-backed healthcare startups fail because they chase rapid growth without sustainable business models or a deep understanding of the market.
Startup Glycomine Lands $115M for Clinical Trial in Ultra-Rare Disease With No Approved Drugs
Glycomine’s lead program is an experimental treatment for PMM2-CDG, an ultra-rare enzyme deficiency often misdiagnosed as cerebral palsy. With encouraging results from an open-label Phase 2 study, the biotech startup is now preparing for a placebo-controlled test that could potentially support a regulatory submission.
Where Does AgeTech Investment Stand?: VCs Weigh Promise Against Payout
At Medicarians 2025, MedCity News Editor-in-Chief Arundhati Parmar explored the state of AgeTech venture capital with three investors. The panelists agreed that despite growing clear opportunities, the AgeTech market currently lacks the dedicated funding, proven business models and major success stories needed for it to take off.
presented by
A Path to Healing: Discovering Arizona’s PTSD Treatment Centers
Explore top PTSD treatment centers in Arizona, offering personalized care, holistic therapies and expert support to help individuals heal and reclaim their lives.
Immunology Startup Merida Bio Unveils $121M and a Lead Program for Graves’ Disease
Merida Biosciences is developing antibody-like drugs designed to selectively eliminate disease-driving autoantibodies while sparing healthy components of the immune system. Graves' disease, which stems from the immune system's attack on the thyroid gland, is the startup’s lead disease target.
An AI Biotech Hauls In $600M, Plus More Funding Highlights to Close 1Q 2025
Isomorphic Labs’ financing led the way for first quarter 2025 financings, but it comes amid headwinds for the biotech sector. Biotech financing activity has been slowing down, analysts say.
Arboretum Ventures Investor Says Startups Are Adapting to Tough Healthcare Fundraising Environment
Charity Tarn, an investor with Arboretum Ventures, will be one of the investor judges for the Pitch Perfect contest at INVEST in Chicago May 20-21. Register today!
How Can Startups Navigate the Difficult Funding Environment
Many experts — be they venture capitalists or private equity investors — shared their advice with biotech entrepreneurs navigating a tough funding environment.
VC Firm Sofinnova Partners Pulls In €1.2B to Deploy Across Life Sciences Investments
Sofinnova Partners aims to invest in 50 to 60 new companies in the life sciences. The infusion of new capital brings the VC firm’s assets under management to more than €4 billion.